Erlocip 150 mg (Erlotinib)
| Active Ingredient: | Erlotinib |
|---|---|
| Dosage Form: | Tablet |
| Available Strength: | 150mg |
| Manufacturer: | Cipla Limited |
| Packaging: | 30 tablets in 1 bottle |
| Therapeutic Use: | Non-small cell lung cancer, Pancreatic cancer |
| Pack Insert/Leaflet: | Yes |
| Production Capacity: | 1 Million Bottle's/Month |
Reviews
There are no reviews yet.